Abstract |
Cinobufagin, a major component of cinobufacini ( huachansu), is an important cardenolidal steroid. Several studies have suggested that cinobufagin has potent anti- cancer effects. The present study examines the apoptosis-inducing activity and the underlying mechanism of action of cinobufagin in osteosarcoma (OS) cells. Our results showed that cinobufagin potently inhibited the proliferation of U2OS, MG63 and SaOS-2 cells. Significant increases in G2/M cell-cycle arrest and apoptosis in OS cells were also observed. The expression levels of several apoptotic proteins were assessed after cinobufagin treatment in U2OS cells. Among them, xIAP, cIAP-1, survivin and Bcl-2 levels decreased remarkably, while the levels of Bax and cleaved-PARP increased. Furthermore, we validated the inhibition of GSK-3β/NF-κB signaling following cinobufagin treatment. Western blots showed a decrease in nuclear p65 protein expression after exposure to different concentrations of cinobufagin, while the phosphorylation of GSK-3β was simultaneously increased. Transduction with constitutively active forms of GSK-3β could protect against the downregulation of p65 and upregulation of cleaved-PARP that are induced by cinobufagin treatment. However, combined treatment with cinobufagin and SB216367 resulted in a significant reduction in p65 and an increase in cleaved-PARP in U2OS cells. Altogether, these results show that cinobufagin is a promising agent for the treatment of OS. These studies are the first to reveal the involvement of the GSK-3β/NF-κB pathway in cinobufagin-induced apoptosis.
|
Authors | Jun-Qiang Yin, Lili Wen, Liang-Cai Wu, Zhen-Hua Gao, Gang Huang, Jin Wang, Chang-Ye Zou, Ping-Xian Tan, Bi-Cheng Yong, Qiang Jia, Jing-Nan Shen |
Journal | Toxicology letters
(Toxicol Lett)
Vol. 218
Issue 2
Pg. 129-36
(Apr 12 2013)
ISSN: 1879-3169 [Electronic] Netherlands |
PMID | 23164673
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Amphibian Venoms
- Antineoplastic Agents
- Apoptosis Regulatory Proteins
- Bufanolides
- NF-kappa B
- RELA protein, human
- Transcription Factor RelA
- huachansu
- Poly(ADP-ribose) Polymerases
- GSK3B protein, human
- Glycogen Synthase Kinase 3 beta
- Glycogen Synthase Kinase 3
- cinobufagin
|
Topics |
- Amphibian Venoms
(analysis, chemistry)
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Apoptosis Regulatory Proteins
(genetics, metabolism)
- Bufanolides
(pharmacology)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Down-Regulation
- Glycogen Synthase Kinase 3
(genetics, metabolism)
- Glycogen Synthase Kinase 3 beta
- Humans
- NF-kappa B
(genetics, metabolism)
- Osteosarcoma
(metabolism)
- Phosphorylation
- Poly(ADP-ribose) Polymerases
(genetics, metabolism)
- Signal Transduction
- Transcription Factor RelA
(genetics, metabolism)
- Transfection
- Up-Regulation
|